ELISA-based detection of open reading frame protein 1 in patients at risk of developing lung cancer.

CONCLUSION: ORF1p can be used to identify patients at high risk of developing lung cancer and may provide an effective, non-invasive risk assessment marker to complement LDCT screening. PMID: 32275987 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32275987?dopt=Abstract

Source: International Journal of Clinical Chemistry - April 6, 2020 Category: Chemistry Authors: Sharp CN, Korte EA, Hosseinejad K, Pitman J, Lavasanifar A, Eichenberger DJ, Sephton S, Cash E, Jortani SA Tags: Clin Chim Acta Source Type: research